eIF4E gene is reported to be recognized as an proto-oncogene in vivo,and the extent of eIF4E overexpression can predict cancer recurrence and outcome in head neck squamous cell carcinoma (HNSCC), breast cancer and lung cancer [9,20]. The gene discussed is EIF4E; the disease is head and neck squamous cell carcinoma.